U.S. market Closed. Opens in 48 minutes

SXTC | China SXT Pharmaceuticals, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-31
Revenue1.93M1.97M2.60M4.78M5.16M7.01M7.02M4.88M
Cost of Revenue1.37M1.55M1.35M1.94M2.46M2.40M3.62M2.57M
Gross Profit553.97K426.27K1.25M2.84M2.70M4.61M3.40M2.31M
Operating Expenses2.65M6.03M6.44M5.04M4.04M2.84M1.77M709.82K
Selling, General & Admin2.46M6.03M6.44M5.04M4.04M2.84M1.77M709.82K
Research & Development184.19KN/AN/AN/AN/AN/AN/AN/A
Other Operating Expenses-39.04K149.51K-181.58K871.65K-73.77K27.14K-1.00N/A
Operating Income-2.09M-5.61M-5.19M-2.20M4.28M1.77M1.63M1.60M
Other Expenses / Income-1.01M149.51K-218.28K-743.79K-14.67M27.14K-4.59K-21.99K
Before Tax Income-3.10M-5.93M-5.41M-2.94M-10.39M1.79M1.63M1.58M
Income Tax Expenses3.00476.78K328.15K-192.68K-101.72K252.23K440.10K395.05K
Net Income-3.10M-5.93M-5.74M-2.75M-10.29M1.54M1.19M1.19M
Interest Expenses544.28K476.78K218.28K-1.62M-3.35M-5.17K-780.00N/A
Basic Shares Outstanding867.42K266.97K41.59K28.78K12.36K10.28K5.94M5.94M
Diluted Shares Outstanding867.42K266.97K41.59K28.78K12.36K10.28K5.94M5.94M
EBITDA-1.89M-5.36M-4.87M-1.85M4.62M1.95M1.76M1.68M
EBITDA Margin-97.95%-271.71%-187.13%-38.76%89.43%27.82%25.02%34.40%
EBIT-2.55M-4.98M-5.19M-4.56M-13.74M1.79M1.63M1.58M
EBIT Margin-132.45%-252.64%-199.43%-95.37%-266.13%25.47%23.18%32.37%
Financial Year End2024-03-312023-03-312022-03-312021-03-312020-03-312019-03-312018-03-312017-03-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙